supplementary information - sartorius · 2020. 2. 17. · supplementary information glossary 175...
Post on 05-Nov-2020
1 Views
Preview:
TRANSCRIPT
Supplementary Information
Supplementary Information Glossary 175
Industrial | Product-specific Terms
Bags, single-use Plastic disposable bag used in bioreactors and for storing liquids,
such as culture media, intermediate products and
biopharmaceuticals
Bioreactor In English-speaking countries, a bioreactor is a vessel used for
cultivating animal or human cells in a culture medium. In non-
English-speaking countries, the term bioreactor is also used
synonymously with the term fermenter to denote a system
used to multiply microorganisms. In either case, the vessel is
used to obtain cells, parts of these or one of their metabolites.
Disposable Used synonymously with “single-use"
Downstream processing Collective term for the various steps that follow fermentation
or cell cultivation (upstream processing) in the production of
biopharmaceuticals; for example, separation, purification and
concentration
FDA - Food and Drug Administration U.S. regulatory agency responsible for ensuring the safety and
efficacy of human and veterinary pharmaceuticals, biological
products, medical devices and foods
Fermentation Technical process used to produce or transform intra- or
extra-cellular substances with the help of microorganisms
Fluid management technologies Technologies and systems for the transportation and storage
of biological liquids
Membrane chromatography Selective separation of mixtures of substances by adsorption
to specifically modified membranes (membrane adsorbers) in
a flowing system
Membrane (filter) Thin film or foil made of polymers; because of the porous
structure, this film is suitable for filtration applications.
Monoclonal antibodies Synthetic antibodies used, in particular, in the treatment of
cancer, HIV and autoimmune diseases
PAT - Process Analytical Technology A strategy for the design, analysis and control of manufacturing
processes according to which quality characteristics of
intermediate or finished products are defined and then analyzed
and monitored using the critical process parameters identified
Purification An important step in downstream processing
Scale-up Transfer of scale or increase in size. Used to denote the
progression of a process that increases in a range from lab scale
to pilot scale to process scale, while retaining the same
technology, materials of construction and geometries
throughout
Single-use | Reusable product Disposable product, i.e., for one-time usage. A reusable product
is designed for repeated use.
Upstream processing In the manufacture of biopharmaceuticals, designates the
various steps that take place for seeding and propagating cells
that produce an active pharmaceutical ingredient
Validation Documented verification that systems, devices and processes
reproducibly deliver the desired result
Glossary
176 Supplementary Information Glossary
Business | Economic Terms
Amortization Amortization relates exclusively to potential reductions in the
value of goodwill and the allocation of the purchase price to
intangible assets acquired as carried out according to IFRS 3
Cash flow The amount of cash earned after paying all expenses and taxes;
i.e., the cash balance of inflows and outflows of funds
Compliance Observance of applicable laws, codes and other relevant rules
and regulations
Constant currencies; currency-adjusted In the presentation of figures, identical exchange rates are used
for each of the comparative periods.
DAX®, TecDAX® German stock indexes of the transaction service provider and
marketplace organizer Deutsche Börse AG
D&O insurance Directors’ and Officers’ liability insurance that covers
Supervisory and Executive Board members and managerial
employees
DVFA | SG The Methods Commission of the Society of Investment
Professionals in Germany (DFVA e.V.) and the Schmalenbach-
Gesellschaft (SG)
EBITDA Earnings before interest, taxes, depreciation and amortization;
in this context, amortization refers exclusively to the purchase
price allocation (PPA) to intangible assets acquired according to
IFRS 3.
EBITDA margin The ratio of EBITDA (earnings before interest, taxes, depreciation
and amortization) to sales
Equity ratio The ratio of equity to the balance sheet total
ERP Stands for “Enterprise Resource Planning”;
IT-based system for resource planning
Extraordinary items Exceptional or one-time expenses and income, such as
acquisition costs, restructuring costs and other non-operating
expenses
Fixed assets The sum of intangible assets, property, plant and equipment and
financial assets
Goodwill The difference between the price paid for a company or business
and its net assets; a form of intangible asset
Holding company A parent company that exists for the purpose of owning a
controlling interest or shares in several legally independent
subsidiaries that are subordinate within the organizational
hierarchy; this holding company conducts its business
exclusively through these subsidiaries.
Market capitalization The total number of shares outstanding of both classes issued by
the company, multiplied by the corresponding share price
Normalized financial result Financial result excluding fair value adjustments of hedging
instruments, as well as excluding non-periodic expenses and
income.
Normalized income tax Underlying income tax, based on underlying profit before tax
and on non-cash amortization.
Prime Standard Market segment of the Frankfurt Stock Exchange with high,
internationally accepted transparency requirements to meet the
needs of companies seeking to attract international investors.
Supply chain management Setup and coordination of integrated flows of materials,
information and finances (supply chains) over the entire value-
added process
Treasury Short- and medium-term liquidity management
Underlying Adjusted to eliminate extraordinary items (see definition
extraordinary item)
Supplementary Information Glossary 177
Other Terms
CRM Abbreviation for “Customer Relationship Management”;
practices, strategies and technologies that companies use to
manage and analyze customer interactions and data to improve
customer retention and drive sales growth
EHS Abbreviation for "Environment, Health and Safety”
EMEA The region comprising Europe, the Middle East and Africa; one
of the three reporting regions in the geographical allocation of
the Sartorius Group besides the Americas and Asia / Pacific
ERP Stands for "Enterprise Resource Planning";
IT-based resource planning system
ESG Abbreviation for “Environment, Social and Governance”; refers
to the three major factors of sustainable corporate management.
GEC Stands for the "Group Executive Committee"; the central
management body of the Sartorius Group. It currently is
comprised of six members: the three Executive Board members
of Sartorius AG and further executives with global responsibility
GHG Abbreviation for “Greenhouse Gas Protocol,” the international
standard for measuring and managing greenhouse gas emissions,
including reporting. The WHO stands for the “World Heath
Organization,” the coordination authority of the United Nations
for international public health
178 Supplementary Information Index
A Acquisitions | 9 | 25 ff. | 34 | 39 | 45 | 49 f. | 57 f. | 65 | 89 f.
| 111 | 116 f. | 132 ff. | 137 | 140 |
Annual financial statements | 13 f. | 53 ff. | 55 f. | 74 f. | 79
| 102 | 116 | 160 | 167
Annual Shareholders’ Meeting | 8 | 12 ff. | 19 | 70 ff. | 139
| 161 | 167 | 183
Appropriation of profits | 54 | 72 | 176
Auditor(s) | 13 | 14 | 55 | 67 | 70 | 74 | 160 | 163 ff.
B
Balance sheet | 9 | 12 | 14 | 37 | 39 ff. | 41 | 51 ff. | 60 f. | 65
| 67 f. | 110 | 112 | 114 ff. | 121 | 124 | 126
| 128 | 132 ff. | 138
Bioprocess Solutions | 8 f. | 22 | 24 f. | 27 | 29 | 32 ff. | 38
|42 ff. | 50 | 54 | 56 | 65 | 114 | 119 f.
|127 | 132 | 134 | 160 | 164
C
Capital expenditures | 23 | 37 | 39 | 41 | 50 | 57 | 59 | 62 f.
| 114 | 120 | 133 | 135 | 147
Cash flow(s) | 23 | 39 | 41 | 60 | 109 | 111 f. | 117 f. | 132 | 134
|138 | 140 | 145 | 154 ff. | 175
Compliance | 12 f. | 55 | 60 f. | 67 f. | 72 ff. | 86 | 89 | 95 f.
|102 f. | 168 | 175
Consolidated financial statements | 12 | 13 | 14 | 22 | 51 | 55
| 67 f. | 74 | 101 | 115 ff.
| 135 | 140 | 148 | 160 ff.
| 165 ff
Corporate governance | 12 f. | 70 ff. | 81 | 95 | 101 | 103 | 160
|171
Currency | 23 | 27 | 29 f. | 48 | 55 | 60 | 62 | 65 | 67 | 109 | 111 f.
|115 ff. | 121 | 129 f. | 132 f. | 135 | 137 ff. | 148 f.
|152 ff. | 158 f.
D
Depreciation | 35 | 52 | 65 | 111 |119 f. | 129 f. |132 ff. | 138 |
Dividend(s) | 8 | 14 | 19 f. | 39 | 51 | 53 | 69 | 75 | 111 ff. | 130
| 139 | 161 | 183
E
Earnings | 19 f. | 23 | 35 f. | 52 | 75 | 77 | 80 ff. | 108 f. |112
| 140
Earnings per share | 36 | 108 | 131
Earnings reserves | 52 | 112 | 126 | 145 | 147
EBIT | 34 ff. | 108 | 111 | 120
EBITDA | 9 | 23 | 27 | 35 | 39 ff. | 43 | 48 | 50 | 60 | 65 | 75 | 116
|119 f. | 156 | 175
Employees | 9 | 14 | 23 | 38 | 44 | 53 | 59 | 61 | 68 | 74 | 85 f.
| 91 ff. | 99 ff. |100 | 101 | 105 | 140 f. | 144
Employee benefits expense | 52 | 78 | 129 | 139 | 159
Equity | 23 | 40 | 51 f. | 110 | 112 f. | 115 f. | 126 | 137 |140
|145 f. | 149 | 151 f. | 154 | 163 | 175
Executive Board | 8 ff. | 12 ff. | 19 f. | 22 f. | 53 ff. | 68 - 78
| 80 | 84 ff. | 92 | 101 f. | 114 | 119 | 121
| 139 f. | 159 ff. | 164 | 168 ff. | 176
F
Financial instruments | 60 | 74 | 114 | 116 | 130 | 138 | 145 ff.
|159
Financing | 13 | 23 | 39 ff. | 50 | 60 | 110 | 115 | 117 | 121 |136
| 148 | 154 f.
Financial result | 20 | 35 f. | 108 | 111 | 117 | 119 f. | 130 | 154
|175
Fixed assets | 51 f. | 111 | 116 | 121 | 129 | 135 f. | 138 |175
Forecast report | 53 | 62 ff.
Foreign exchange, foreign exchange rates | 41 | 60 | 147 | 151
| 153 f.
G Group companies | 54 f. | 60 | 67 f. | 120 | 141
Group Executive Committee | 10 f. | 19 | 54 | 73 | 92 | 97 | 187
Group financial statements | 12 | 13 | 14 | 22 | 51 | 55 | 67 f.
| 74 | 101 | 115 ff. | 135 | 140 | 148
| 160 ff. | 165 ff
Group structure | 22 f. | 85 | 101
Group management report | 14 | 21 - 106 | 51 | 67 | 74 | 85
| 104 | 159 | 161 ff. | 165 ff.
I Intangible assets | 75 | 110 f. | 118 | 125 | 130 |132 ff. | 137
| 175
Interest income | 142 | 152
Inventories | 39 | 110 f. | 125 ff. | 137 f. f.
Investments | 23 | 37 | 39 | 41 | 50 | 57 | 59 | 62 f. | 114 | 120
|133 | 135 | 147
Investor relations | 18 | 86 | 168
Index
Supplementary Information Index 179
L
Lab Products & Services | 8 | 14 | 24 | 26 | 29 | 32 ff. | 38 | 47 ff.
|54 | 65 | 119 f. | 132 | 160 | 164
Liabilities | 35 | 39 ff. | 52 | 60 | 110 f. | 116 ff. | 121 | 125 ff.
| 130 | 137 | 144 | 146 | 1148 ff. | 154 ff.
M
Marketing | 22 | 27 | 34 | 38 | 44 | 54 | 86 | 91 | 129 | 168
N
Net debt | 23 | 39 ff. | 50 | 60 | 156
Net profit | 19 f. | 23 | 35 f. | 52 | 75 | 77 | 80 ff. | 108 f.
|112 | 140.
Note loans | 39 ff. | 69 | 148 | 151 | 156
O
Ordinary shares | 8 | 14 | 16 | 18 ff. | 36 | 53 | 69 | 74 | 108 | 113
| 131 | 138 f. | 159 | 161
P
Pension commitments | 80 | 84 | 118 | 140 f. | 161
Phantom stock, phantom stock units | 75 ff. | 81 f. | 159
Preference share(s) | 8 | 14 | 16 | 18 ff. | 36 | 53 | 69 | 74 | 108
| 113 | 131 | 138 f. | 159 | 161
Procurement | 54 | 56 | 60 f. | 147
Production | 8 | 12 | 22 | 24 f. | 27 | 30 ff. | 37 ff. | 41 | 44 | 46
|49 f. | 55 ff. | 60 f. | 63 f. | 85 f. | 88 - 93 | 97 ff.
|129 | 147 f. | 152 | 174
Products | 8 f. | 22 | 24 ff. | 30 f. | 37 | 44 ff. | 49 | 54 | 57 f. | 60
|64 f. | 71 | 86 | 89 | 91 | 97 f. | 100 ff. | 119| 127 f.
| 132 | 134 | 174
Profit | 12 f. | 18 | 23 | 34 ff. | 37 | 40 | 43 |48 | 50 ff. | 55 f.
| 59 ff. | 65 | 68 | 71 | 76 | 78 | 86 | 89 | 91 | 105 | 108 f.
| 111 f. | 116 ff. | 126 | 130 f. | 137 ff. | 147 | 149 | 152
| 154 f. | 159 | 163 f. | 175
Property, plant and equipment | 39 | 52 | 110 f. | 117 | 119 f.
| 125 | 135 ff.
Provisions | 52 | 110 f. | 118 | 137 | 140 | 143 f.
R
Ratio of Net Debt to Underlying EBITDA | 40
Regions | 8 | 12 | 33f. | 43 | 48 ff. | 62 | 65 | 91 | 96 | 120 | 127
|157 | 176
Remuneration of the Executive Board | 12
Research and Development | 28 | 34 | 37 f. | 53 | 89 f. | 129
Reserves | 52 | 110 f. | 118 | 137 | 140 | 143 f.
Restructuring | 119 | 143 | 175
Results | 12 f. | 18 | 23 | 34 ff. | 37 | 40 | 43 | 48 | 50 ff. | 55 f.
| 59 ff. | 65 | 68 | 71 | 76 | 78 | 86 | 89 | 91 | 105 | 108 f.
| 111 f. | 116 ff. | 126 | 130 f. | 137 ff. | 147 | 149 | 152
| 154 f. | 159 | 163 f. | 175
Retained profit | 52 | 112 | 126 | 145 | 147
Risk management system | 53 ff. | 68
Risk and opportunities report | 53 - 61 | 73 | 101 f.
S
Sales (and distribution) | 8 | 22 | 25 | 27 | 34 f. | 38 | 44 | 49 | 56 f.
| 65 | 86 | 91 | 97 | 108 | 119 | 125 | 127
| 129 | 135 | 138 | 168
Sales revenue | 8 f. | 12 | 16 | 23 | 25 | 27 | 29 | 30 f. | 33 ff.
| 37 | 39 | 43 | 48 | 50 ff. | 58 | 60 | 63 ff. | 75
| 91 | 97 f. | 108 |114 | 118 | 120 | 124 | 126 ff.
| 140 | 148 f. | 152 | 154 | 164 | 175
Sartorius Stedim Biotech | 22 | 35 | 51 | 83 ff. | 90 | 122 | 134
|139 | 168 | 170 f.
Segment reports | 119 f.
Shareholder structure | 19
Share(s) | 9 | 14 | 16 ff. | 22 f. | 35 f. | 53 | 65 | 69 f. | 74 ff.
| 78 f. | 104 f. | 108 | 112 ff. | 121 | 131 | 138 f.| 159
| 161 ff. | 167 | 175
Statement of profit or loss | 35 | 52 | 108 f. | 116 f. | 126 ff.
| 134 f. | 136 | 138 | 140 f. | 153
| 158 | 163
Stedim transaction | 134
Supervisory Board | 8 | 12 ff. | 19 f. | 22 | 53 ff. | 67 ff. | 83 f.
| 104 f. | 114 | 159 ff. | 164 f. | 167 ff.
Supply chain management | 46 | 49 | 56 | 175
Sustainability | 61 | 85 ff. | 101 | 105
T
Taxes | 35 f. | 52 | 95 | 108 ff. | 118 ff. | 125 | 130 | 132 | 137 ff.
| 144 | 154 f. | 175
Treasury | 41 | 152 | 157 | 175
W
Working capital | 23 | 39 ff. | 57 | 148
190 Supplementary Information A Local Presence Worldwide
SalesProduction | Production and Sales
The Americas
Oakville, ON, CanadaBohemia, NY, USABoston, MA, USAAnn Arbor, MI, USAArvada, CO, USANew Oxford, PA, USAAlbuquerque, NM, USAMexico City, MexicoYauco, Puerto RicoSão Paulo, BrazilBuenos Aires, ArgentinaLima, Peru
A Local Presence Worldwide
191Supplementary Information A Local Presence Worldwide
Europe | Africa
Dublin, IrelandRoyston, UKStonehouse, UKEpsom, UKGlasgow, UKBrussels, BelgiumDourdan, FranceAubagne, FranceLourdes, France Florence, ItalyMilan, ItalyMadrid, SpainBarcelona, Spain
Kajaani, FinlandHelsinki, FinlandMalmo, SwedenUmeå, SwedenSt. Petersburg, RussiaGoettingen, GermanyGuxhagen, GermanyLaupheim, GermanyPoznan, PolandBudapest, HungaryVienna, AustriaTagelswangen, SwitzerlandMohamdia, TunisiaBeit Haemek, Israel
Asia | Pacific
Beijing, ChinaShanghai, ChinaHong Kong, ChinaSeoul, South KoreaTokyo, JapanHanoi, VietnamBangkok, ThailandBangalore, IndiaKuala Lumpur, MalaysiaSingapore, SingaporeMelbourne, Australia
182 Supplementary Information A Local Presence Worlwide
Supplementary Information Financial Schedule 183
Financial Schedule
Annual Shareholders’ Meeting in Goettingen, Germany March 26, 2020
Payment of dividends1) March 31, 2020
Publication of first-quarter figures for 2020 April 21, 2020
Publication of first-half figures for 2020 July 21, 2020
Publication of nine-month figures for 2020 October 20, 2020
Publication of preliminary figures for fiscal 2020 January 2021
Annual press conference in Goettingen, Germany February 2021
Annual Shareholders’ Meeting in Goettingen, Germany March, 2021
Publication of first-quarter figures for 2020 April 2021
1) Subject to approval by the Annual Shareholders‘ Meeting
Contacts
Petra Kirchhoff Head of Corporate Communications & IR
Phone: 0551.308.1686 petra.kirchhoff@sartorius.com
Ben Orzelek Head of Investor Relations Phone: 0551.308.1668 ben.orzelek@sartorius.com
Katharina Tillmanns-Pelzer Manager Corporate Responsibility Phone: 0551.308.2893 katharina.tillmanns@sartorius.com
This is a translation of the original German-language annual report.
About This Publication
Published by Sartorius AG Corporate Communications 37070 Goettingen, Germany
Editorial Deadline February 18, 2019
Published on February 19, 2019
Financial Reporting System firesys firesys GmbH Frankfurt | Main, Germany
Photography Peter Ginter
Lohmar, Germany
Frank Stefan Kimmel Goettingen
Sartorius AG Otto-Brenner-Strasse 2037079 Goettingen, Germany
Phone: +49.551.308.0Fax: +49.551.308.3289
info@sartorius.comwww.sartorius.com
©Sar
tori
us A
G |
Pri
nted
in G
erm
any
turning science into solutions
top related